Previous Close | 0.0100 |
Open | 0.0000 |
Bid | 0.0100 x N/A |
Ask | 0.0150 x N/A |
Day's Range | 0.0100 - 0.0100 |
52 Week Range | 0.0100 - 0.1500 |
Volume | |
Avg. Volume | 153,809 |
Market Cap | 3.149M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0340 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jan 22, 2018 |
1y Target Est | N/A |
VANCOUVER, BC / ACCESSWIRE / June 29, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it has completed a second closing of its previously announced non-brokered private placement.
VANCOUVER, BC / ACCESSWIRE / June 8, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it has completed a first closing of a non-brokered private placement.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / May 14, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company") (CSE:LUV)(FSE:G1Q0), is pleased to announce that it has completed its acquisition (the "Acquisition") of MicroDoz Theraphy Inc.